You are here

  • Home
  • Archive
  • Volume 78, Issue 1
  • Antipsychotics, cognitive decline and death in Alzheimer’s disease: the London and South-East Region Alzheimer’s Disease longitudinal study

Article Text

Article menu
Download PDFPDF
Editorial commentary
Antipsychotics, cognitive decline and death in Alzheimer’s disease: the London and South-East Region Alzheimer’s Disease longitudinal study

https://doi.org/10.1136/jnnp.2006.100586

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests: DA has received research support, assistance to attend conferences, and honoraria for lectures and consultancy services from companies which market antipsychotic drugs, including Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Janssen Cilag, Novartis and Pfizer.

    Linked Articles